Form 8-K - Current report:
SEC Accession No. 0001193125-24-253769
Filing Date
2024-11-08
Accepted
2024-11-08 09:30:28
Documents
13
Period of Report
2024-11-07
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d893574d8k.htm   iXBRL 8-K 27025
  Complete submission text file 0001193125-24-253769.txt   146753

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20241107.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20241107_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20241107_pre.xml EX-101.PRE 10822
15 EXTRACTED XBRL INSTANCE DOCUMENT d893574d8k_htm.xml XML 3498
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 241438251
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)